EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

María José Serna, José Miguel Rivera-Caravaca, Raquel López-Gálvez, Eva Soler-Espejo, Gregory Y H Lip, Francisco Marín, Vanessa Roldán

Revista Española de Cardiología (English Edition) · 2024-10 · 77 (10) · 835-842

DOI: 10.1016/j.rec.2024.02.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Cardiología (English Edition), 2024-10. Verfasst von María José Serna und 6 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Hematología y Oncología Médica, Hospital General Universitario Morales Meseguer, Universidad de Murcia, Instituto Murciano de Investigaci…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke, Hemorrhage. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares, Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Stroke and bleeding risks in atrial fibrillation (AF) are often assessed at baseline to predict outcomes years later. We investigated whether dynamic changes in CHA2DS2-VASc and HAS-BLED scores over time modify risk prediction. METHODS: We included patients with AF who were stable while taking vitamin K antagonists. During a 6-year follow-up, all ischemic strokes/transient ischemic attacks (TIAs) and major bleeding events were recorded. CHA2DS2-VASc and HAS-BLED were recalculated every 2-years and tested for clinical outcomes at 2-year periods. RESULTS: We included 1361 patients (mean CHA2DS2-VASc and HAS-BLED 4.0±1.7 and 2.9±1.2). During the follow-up, 156 (11.5%) patients had an ischemic stroke/TIA and 269 (19.8%) had a major bleeding event. Compared with the baseline CHA2DS2-VASc, the CHA2DS2-VASc recalculated at 2 years had higher predictive ability for ischemic stroke/TIA during the period from 2 to 4 years. Integrated discrimination improvement (IDI) and net reclassification improvement (NRI) showed improvements in sensitivity and better reclassification. The CHA2DS2-VASc recalculated at 4 years had better predictive performance than the baseline CHA2DS2-VASc during the period from 4 to 6 years, with an improvement in IDI and an enhancement of the reclassification. The recalculated HAS-BLED at 2-years had higher predictive ability than the baseline score for major bleeding during the period from 2 to 4 years, with significant improvements in sensitivity and reclassification. A slight enhancement in sensitivity was observed with the HAS-BLED score recalculated at 4 years compared with the baseline score. CONCLUSIONS: In AF patients, stroke and bleeding risks are dynamic and change over time. The CHA2DS2-VASc and HAS-BLED scores should be regularly reassessed, particularly for accurate stroke risk prediction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationIschemic StrokeHemorrhageHumansMaleFemaleAgedRisk AssessmentAnticoagulantsFollow-Up StudiesRisk FactorsMiddle AgedStroke

Stichwörter der Autor:innen

Atrial fibrillationCHA(2)DS(2)-VAScEscalas de riesgoEstratificación del riesgoFibrilación auricularHAS-BLEDHemorragiaHemorrhageIctusRisk scoresRisk stratificationStroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Servicio de Hematología y Oncología Médica, Hospital General Universitario Morales Meseguer, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.
  • Facultad de Enfermería, Universidad de Murcia, Murcia, Spain; Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-…
  • Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, Universidad de Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), El Palmar, Murcia, Spain; Centro de Investigación B…
  • Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Department of Clinical Medicine, Aalborg Thrombosis Research Unit, Aalborg Universi…

Förderung

  • European Regional Development Fund
  • Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares
  • Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
  • Instituto de Salud Carlos III

Zitieren

APA

Serna, M. J., Rivera-Caravaca, J. M., López-Gálvez, R., Soler-Espejo, E., Lip, G. Y. H., Marín, F., & Roldán, V. (2024). Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Revista Española de Cardiología (English Edition), 77(10), 835-842. https://doi.org/10.1016/j.rec.2024.02.011

Vancouver

Serna MJ, Rivera-Caravaca JM, López-Gálvez R, Soler-Espejo E, Lip GYH, Marín F, et al. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Revista Española de Cardiología (English Edition). 2024;77(10):835-842. doi:10.1016/j.rec.2024.02.011

BibTeX
@article{Serna2024,
  author = {Serna, María José and Rivera-Caravaca, José Miguel and López-Gálvez, Raquel and Soler-Espejo, Eva and Lip, Gregory Y H and Marín, Francisco and Roldán, Vanessa},
  title = {Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2024},
  volume = {77},
  number = {10},
  pages = {835--842},
  doi = {10.1016/j.rec.2024.02.011}
}
Kostenlos starten →